Q3 2024 · 13F-HR
ADAR1 Capital Management, LLCholdings as filed
Filed 2024-11-14 · accession 0001940267-24-000005
$614.9M
Reported value
278
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 23282W605 | CYTK | CYTOKINETICS INC | $48.1M | 7.82% | 911,182 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $44.2M | 7.18% | 981,295 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $36.9M | 6.00% | 1,448,470 | Common | SOLE |
| 02072L565 | BOXX | EA SERIES TRUST | $35.2M | 5.73% | 323,382 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $34.9M | 5.68% | 3,025,450 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $32.3M | 5.25% | 1,131,707 | Common | SOLE |
| G7709Q104 | RPRX | ROYALTY PHARMA PLC | $31.0M | 5.05% | 1,096,666 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $25.8M | 4.20% | 445,068 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $24.1M | 3.92% | 161,402 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $15.3M | 2.49% | 3,770,649 | Common | SOLE |
| 98887Q104 | ZLAB | ZAI LAB LTD | $12.9M | 2.09% | 532,454 | Common | SOLE |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS INTL | $10.9M | 1.77% | 436,668 | Common | SOLE |
| G1000R101 | AAM | AA MISSION ACQUISITION CORP | $10.1M | 1.65% | 1,010,199 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $8.8M | 1.44% | 729,401 | Common | SOLE |
| 03879J100 | ABUS | ARBUTUS BIOPHARMA CORP | $8.0M | 1.31% | 2,089,321 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $8.0M | 1.30% | 1,145,592 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $7.7M | 1.25% | 153,286 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $7.6M | 1.24% | 1,571,705 | Common | SOLE |
| G70077105 | PCSC | PERCEPTIVE CAP SOLUTIONS COR | $7.5M | 1.22% | 750,000 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $6.9M | 1.12% | 342,262 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $6.7M | 1.10% | 350,206 | Common | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $6.5M | 1.05% | 192,720 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $6.0M | 0.98% | 521,612 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $6.0M | 0.97% | 569,008 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $5.7M | 0.93% | 29,625 | Common | SOLE |
| 68218J103 | OABI | OMNIAB INC | $5.7M | 0.92% | 1,337,302 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $5.4M | 0.88% | 143,104 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $4.5M | 0.73% | 88,425 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $4.5M | 0.73% | 530,200 | CALL | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $4.2M | 0.69% | 404,138 | Common | SOLE |
| 78464A870 | XBI | SPDR SER TR | $4.0M | 0.64% | 40,000 | PUT | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $3.9M | 0.63% | 127,159 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $3.8M | 0.63% | 376,737 | Common | SOLE |
| 00091E109 | ABSI | ABSCI CORPORATION | $3.8M | 0.62% | 1,005,750 | Common | SOLE |
| 29260Y109 | 0C3 | ENDEAVOR GROUP HLDGS INC | $3.5M | 0.57% | 122,807 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $3.4M | 0.55% | 57,183 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $3.3M | 0.53% | 118,738 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $3.1M | 0.51% | 742,634 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $3.0M | 0.48% | 101,826 | Common | SOLE |
| 00439U104 | GRCE | ACASTI PHARMA INC | $2.9M | 0.47% | 959,571 | Common | SOLE |
| 746964105 | QTTB | Q32 BIO INC | $2.9M | 0.47% | 64,245 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $2.8M | 0.45% | 246,128 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $2.5M | 0.41% | 557,159 | Common | SOLE |
| 720795202 | — | PIERIS PHARMACEUTICALS INC | $2.4M | 0.39% | 144,641 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $2.4M | 0.39% | 319,185 | Common | SOLE |
| 670100205 | NVO | NOVO-NORDISK A S | $2.4M | 0.39% | 20,000 | PUT | SOLE |
| 15117F807 | CLRBUSD | CELLECTAR BIOSCIENCES INC | $2.2M | 0.36% | 1,022,161 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $2.1M | 0.34% | 74,431 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $2.0M | 0.33% | 105,000 | CALL | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $2.0M | 0.33% | 44,351 | Common | SOLE |
| 78468R663 | BIL | SPDR SER TR | $2.0M | 0.33% | 21,786 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $2.0M | 0.32% | 428,802 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $1.9M | 0.32% | 108,171 | Common | SOLE |
| 483119202 | KALAEUR | KALA BIO INC | $1.7M | 0.28% | 306,067 | Common | SOLE |
| 500946108 | KRRO | KORRO BIO INC | $1.7M | 0.27% | 49,451 | Common | SOLE |
| 01438T106 | ALDX | ALDEYRA THERAPEUTICS INC | $1.6M | 0.26% | 302,212 | Common | SOLE |
| 45783C200 | TIL | INSTIL BIO INC | $1.6M | 0.26% | 23,707 | Common | SOLE |
| G33033104 | KDK | ARES ACQUISITION CORP II | $1.5M | 0.24% | 138,966 | Common | SOLE |
| 58155Q103 | MCK | MCKESSON CORP | $1.5M | 0.24% | 3,000 | CALL | SOLE |
| 670100205 | NVO | NOVO-NORDISK A S | $1.2M | 0.19% | 10,000 | CALL | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $1.2M | 0.19% | 10,000 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $1.2M | 0.19% | 23,457 | Common | SOLE |
| 29415J106 | — | ENVVENO MEDICAL CORPORATION | $1.2M | 0.19% | 348,263 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $1.2M | 0.19% | 10,097 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $1.1M | 0.18% | 22,564 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $1.1M | 0.18% | 27,903 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $1.1M | 0.17% | 43,900 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $1.1M | 0.17% | 10,442 | Common | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $1.1M | 0.17% | 903,959 | Common | SOLE |
| G29687103 | AVDL | AVADEL PHARMACEUTICALS PLC | $1.1M | 0.17% | 80,900 | Common | SOLE |
| 451033708 | IBIO | IBIO INC | $1.1M | 0.17% | 476,212 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $1.0M | 0.17% | 35,950 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $1.0M | 0.17% | 15,200 | Common | SOLE |
| 49372L209 | 2KZ0 | KEZAR LIFE SCIENCES INC | $1.0M | 0.17% | 1,338,273 | Common | SOLE |
| 055477103 | BCAX | BICARA THERAPEUTICS INC | $1.0M | 0.17% | 40,440 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $1.0M | 0.17% | 93,284 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $1.0M | 0.17% | 1,150 | Common | SOLE |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $996,235 | 0.16% | 743,459 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $980,478 | 0.16% | 13,400 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $946,359 | 0.15% | 21,300 | Common | SOLE |
| 761330109 | RVNCEUR | REVANCE THERAPEUTICS INC | $945,442 | 0.15% | 182,166 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $939,900 | 0.15% | 24,100 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $915,630 | 0.15% | 871 | Common | SOLE |
| 58155Q103 | MCK | MCKESSON CORP | $914,677 | 0.15% | 1,850 | Common | SOLE |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $909,953 | 0.15% | 54,358 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $886,719 | 0.14% | 7,100 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $851,851 | 0.14% | 25,900 | Common | SOLE |
| 28658R106 | CLYM | ELIEM THERAPEUTICS INC | $831,925 | 0.14% | 163,443 | Common | SOLE |
| G0131Y100 | ANSC | AGRICULTURE & NAT SOL ACQ CO | $831,747 | 0.14% | 80,362 | Common | SOLE |
| 05351W103 | AGREUR | AVANGRID INC | $823,170 | 0.13% | 23,000 | Common | SOLE |
| G52443101 | KVACU | KEEN VISION ACQUISITION CORP | $804,750 | 0.13% | 75,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $797,280 | 0.13% | 15,100 | CALL | SOLE |
| 69366J200 | PTCT | PTC THERAPEUTICS INC | $742,000 | 0.12% | 20,000 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $739,836 | 0.12% | 53,111 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $732,717 | 0.12% | 373,835 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $732,472 | 0.12% | 40,290 | Common | SOLE |
| 49721T507 | KPRX | KIORA PHARMACEUTICALS INC | $719,377 | 0.12% | 196,551 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $715,735 | 0.12% | 220,906 | Common | SOLE |
| 73939C106 | — | POWERSCHOOL HOLDINGS INC | $684,300 | 0.11% | 30,000 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $660,071 | 0.11% | 23,007 | Common | SOLE |
| 05153U107 | AURA | AURA BIOSCIENCES INC | $656,337 | 0.11% | 73,663 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $645,525 | 0.10% | 22,500 | CALL | SOLE |
| G6363K106 | — | NABORS ENERGY TRANSITION COR | $638,534 | 0.10% | 59,900 | Common | SOLE |
| 68404L201 | OPCH | OPTION CARE HEALTH INC | $626,000 | 0.10% | 20,000 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $590,590 | 0.10% | 13,000 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $586,200 | 0.10% | 30,000 | Common | SOLE |
| G89229119 | — | TMT ACQUISITION CORP | $562,000 | 0.09% | 50,000 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $561,144 | 0.09% | 11,856 | Common | SOLE |
| G4766E116 | INDV | INDIVIOR PLC | $527,056 | 0.09% | 54,057 | Common | SOLE |
| 574795100 | MASI | MASIMO CORP | $519,187 | 0.08% | 3,894 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $516,781 | 0.08% | 57,166 | Common | SOLE |
| 87615L107 | TH | TARGET HOSPITALITY CORP | $511,465 | 0.08% | 65,741 | Common | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $505,314 | 0.08% | 251,400 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $504,900 | 0.08% | 10,000 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $502,452 | 0.08% | 20,400 | Common | SOLE |
| 97717Y527 | USFR | WISDOMTREE TR | $502,200 | 0.08% | 10,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $497,548 | 0.08% | 17,252 | Common | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $490,865 | 0.08% | 163,078 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $485,171 | 0.08% | 18,178 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $471,750 | 0.08% | 5,100 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $449,501 | 0.07% | 7,100 | Common | SOLE |
| 88338N206 | TXMD | THERAPEUTICSMD INC | $448,466 | 0.07% | 270,160 | Common | SOLE |
| 09090D301 | — | BIOMX INC | $441,354 | 0.07% | 432,700 | Common | SOLE |
| 015857105 | AQN | ALGONQUIN PWR UTILS CORP | $436,000 | 0.07% | 80,000 | Common | SOLE |
| 62459M206 | — | MOVANO INC | $416,494 | 0.07% | 1,159,826 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $411,287 | 0.07% | 416,958 | Common | SOLE |
| G1933S101 | CASIF | CASI PHARMACEUTICALS INC | $399,384 | 0.06% | 64,835 | Common | SOLE |
| 00534B100 | ADGM | ADAGIO MED HLDGS INC | $384,061 | 0.06% | 148,861 | Common | SOLE |
| 78667J108 | SG7 | SAGE THERAPEUTICS INC | $372,913 | 0.06% | 51,650 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $372,599 | 0.06% | 23,302 | Common | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $369,709 | 0.06% | 24,307 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $369,390 | 0.06% | 12,560 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $355,278 | 0.06% | 23,100 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $351,450 | 0.06% | 5,000 | CALL | SOLE |
| 88025U109 | TXG | 10X GENOMICS INC | $338,700 | 0.06% | 15,000 | Common | SOLE |
| 75989R107 | RNXT | RENOVORX INC | $334,104 | 0.05% | 315,192 | Common | SOLE |
| 67190B104 | OAKU | OAK WOODS ACQUISITION CORP | $333,000 | 0.05% | 30,000 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $330,867 | 0.05% | 3,962 | Common | SOLE |
| M8001Q126 | PYPD | POLYPID LTD | $323,023 | 0.05% | 93,902 | Common | SOLE |
| G5212E105 | — | JVSPAC ACQUISITION CORP | $310,200 | 0.05% | 30,000 | Common | SOLE |
| 00288U106 | ABCL | ABCELLERA BIOLOGICS INC | $298,951 | 0.05% | 114,981 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $297,499 | 0.05% | 15,816 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $290,802 | 0.05% | 10,200 | CALL | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $289,495 | 0.05% | 11,260 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $287,700 | 0.05% | 10,000 | Common | SOLE |
| 92941V308 | VYNE | VYNE THERAPEUTICS INC | $287,386 | 0.05% | 152,865 | Common | SOLE |
| 24661P807 | DCTH | DELCATH SYS INC | $280,400 | 0.05% | 31,052 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $274,193 | 0.04% | 11,187 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $266,000 | 0.04% | 35,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $265,282 | 0.04% | 3,634 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $263,755 | 0.04% | 53,500 | Common | SOLE |
| 462837105 | UCFI | IRON HORSE ACQUISITIONS CORP | $254,750 | 0.04% | 25,000 | Common | SOLE |
| 92915B106 | VYGR | VOYAGER THERAPEUTICS INC | $237,709 | 0.04% | 40,634 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $236,327 | 0.04% | 113,075 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $226,726 | 0.04% | 11,705 | Common | SOLE |
| 16934W106 | CMRXEUR | CHIMERIX INC | $223,718 | 0.04% | 240,557 | Common | SOLE |
| 07725L102 | ONC | BEIGENE LTD | $219,571 | 0.04% | 978 | Common | SOLE |
| 88032L605 | TENX | TENAX THERAPEUTICS INC | $215,984 | 0.04% | 62,423 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $213,542 | 0.03% | 97,955 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $209,500 | 0.03% | 2,500 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $209,436 | 0.03% | 9,206 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $206,015 | 0.03% | 24,702 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $199,213 | 0.03% | 55,802 | Common | SOLE |
| 85209E109 | — | SPRUCE BIOSCIENCES INC | $191,725 | 0.03% | 403,716 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $186,722 | 0.03% | 17,800 | CALL | SOLE |
| 21217B100 | CTNM | CONTINEUM THERAPEUTICS INC | $171,628 | 0.03% | 8,967 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $169,950 | 0.03% | 5,000 | Common | SOLE |
| 67079A102 | — | NUVEI CORPORATION | $166,750 | 0.03% | 5,000 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $164,450 | 0.03% | 5,000 | CALL | SOLE |
| 65343E108 | NXTCEUR | NEXTCURE INC | $164,418 | 0.03% | 120,013 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $163,776 | 0.03% | 14,143 | Common | SOLE |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $158,738 | 0.03% | 244,966 | Common | SOLE |
| 00289Y206 | ABEO | ABEONA THERAPEUTICS INC | $153,715 | 0.02% | 24,322 | Common | SOLE |
| G1148A101 | BKHA | BLACK HAWK ACQUISITION CORP | $153,600 | 0.02% | 15,000 | Common | SOLE |
| 363225202 | GALT | GALECTIN THERAPEUTICS INC | $152,075 | 0.02% | 55,300 | PUT | SOLE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $150,502 | 0.02% | 101,008 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $147,423 | 0.02% | 15,700 | Common | SOLE |
| G7258M108 | — | PROPERTYGURU GROUP LTD | $132,200 | 0.02% | 20,000 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $131,771 | 0.02% | 2,637 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $129,458 | 0.02% | 1,140 | Common | SOLE |
| L7579L106 | — | PERIMETER SOLUTIONS SA | $121,050 | 0.02% | 9,000 | Common | SOLE |
| 03212B103 | AMPY | AMPLIFY ENERGY CORP NEW | $120,642 | 0.02% | 18,475 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $116,950 | 0.02% | 5,000 | Common | SOLE |
| 22053A107 | — | QUINCE THERAPEUTICS INC | $110,964 | 0.02% | 142,958 | Common | SOLE |
| 08862L103 | — | BEYOND AIR INC | $109,467 | 0.02% | 282,131 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $103,500 | 0.02% | 90,000 | Common | SOLE |
| 00182C103 | ANIP | ANI PHARMACEUTICALS INC | $101,422 | 0.02% | 1,700 | Common | SOLE |
| 75629V104 | RXRX | RECURSION PHARMACEUTICALS IN | $98,850 | 0.02% | 15,000 | Common | SOLE |
| 87184Q206 | SYRS | SYROS PHARMACEUTICALS INC | $96,750 | 0.02% | 45,000 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $96,120 | 0.02% | 12,000 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $92,850 | 0.02% | 9,285 | Common | SOLE |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $88,080 | 0.01% | 67,754 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $86,540 | 0.01% | 2,000 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $84,348 | 0.01% | 1,200 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $82,520 | 0.01% | 4,000 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $79,421 | 0.01% | 4,300 | Common | SOLE |
| G01490112 | — | AI TRANSN ACQUISITION CORP | $78,600 | 0.01% | 7,500 | Common | SOLE |
| 45175G108 | — | IKENA ONCOLOGY INC | $77,219 | 0.01% | 44,635 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $74,180 | 0.01% | 8,727 | Common | SOLE |
| 92673K108 | VIGL | VIGIL NEUROSCIENCE INC | $73,906 | 0.01% | 21,737 | Common | SOLE |
| 46564T107 | ITIEUR | ITERIS INC NEW | $71,400 | 0.01% | 10,000 | Common | SOLE |
| 78667J108 | SG7 | SAGE THERAPEUTICS INC | $68,590 | 0.01% | 9,500 | CALL | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $64,860 | 0.01% | 6,000 | Common | SOLE |
| 126650100 | CVS | CVS HEALTH CORP | $62,880 | 0.01% | 1,000 | Common | SOLE |
| 746237106 | PRTCY | PURETECH HEALTH PLC | $61,845 | 0.01% | 3,000 | Common | SOLE |
| 384747101 | GRAL | GRAIL INC | $60,558 | 0.01% | 4,401 | Common | SOLE |
| 955306105 | WST | WEST PHARMACEUTICAL SVSC INC | $60,032 | 0.01% | 200 | Common | SOLE |
| G4095J109 | GLRE | GREENLIGHT CAPITAL RE LTD | $59,855 | 0.01% | 4,385 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $59,629 | 0.01% | 110 | Common | SOLE |
| 68622V106 | OGN | ORGANON & CO | $59,303 | 0.01% | 3,100 | Common | SOLE |
| 896945201 | TRIP | TRIPADVISOR INC | $57,960 | 0.01% | 4,000 | Common | SOLE |
| 046353108 | AZNN | ASTRAZENECA PLC | $54,537 | 0.01% | 700 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $53,922 | 0.01% | 600 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $53,550 | 0.01% | 15,000 | CALL | SOLE |
| 140755109 | CARAEUR | CARA THERAPEUTICS INC | $49,116 | 0.01% | 159,469 | Common | SOLE |
| 25460G716 | LABDUSD | DIREXION SHS ETF TR | $49,056 | 0.01% | 8,400 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $48,544 | 0.01% | 6,560 | Common | SOLE |
| 31572Q808 | FGENEUR | FIBROGEN INC | $48,193 | 0.01% | 120,663 | Common | SOLE |
| 655664100 | JWNUSD | NORDSTROM INC | $44,980 | 0.01% | 2,000 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $44,730 | 0.01% | 3,000 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $44,537 | 0.01% | 37,743 | Common | SOLE |
| 039697107 | ARDX | ARDELYX INC | $44,096 | 0.01% | 6,400 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $42,455 | 0.01% | 27,931 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $41,100 | 0.01% | 10,000 | Common | SOLE |
| 90385V107 | UCTT | ULTRA CLEAN HLDGS INC | $39,930 | 0.01% | 1,000 | Common | SOLE |
| 92536C103 | VERUEUR | VERU INC | $39,219 | 0.01% | 51,000 | Common | SOLE |
| 55028X109 | 4NX1 | LUMOS PHARMA INC | $38,700 | 0.01% | 10,000 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $37,040 | 0.01% | 2,000 | Common | SOLE |
| 747324101 | PYXS | PYXIS ONCOLOGY INC | $36,700 | 0.01% | 10,000 | Common | SOLE |
| 34962G208 | FBRX | FORTE BIOSCIENCES INC | $33,540 | 0.01% | 6,000 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $32,400 | 0.01% | 10,000 | CALL | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $31,680 | 0.01% | 1,000 | Common | SOLE |
| G1000R127 | — | AA MISSION ACQUISITION CORP | $30,306 | 0.00% | 505,099 | Common | SOLE |
| 071734107 | BHC | BAUSCH HEALTH COS INC | $30,192 | 0.00% | 3,700 | Common | SOLE |
| 63001N106 | NATL | NCR ATLEOS CORPORATION | $28,530 | 0.00% | 1,000 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $28,042 | 0.00% | 700 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $27,558 | 0.00% | 600 | Common | SOLE |
| 62886E108 | VYX | NCR VOYIX CORPORATION | $27,140 | 0.00% | 2,000 | Common | SOLE |
| G97822103 | PRGO | PERRIGO CO PLC | $26,230 | 0.00% | 1,000 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $23,390 | 0.00% | 1,000 | PUT | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $23,204 | 0.00% | 553 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $19,728 | 0.00% | 20,000 | CALL | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $18,203 | 0.00% | 100 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $17,421 | 0.00% | 300 | CALL | SOLE |
| 45826J105 | NTLA | INTELLIA THERAPEUTICS INC | $16,440 | 0.00% | 800 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $15,980 | 0.00% | 2,000 | Common | SOLE |
| 75120L100 | — | RALLYBIO CORP | $15,561 | 0.00% | 13,300 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $15,075 | 0.00% | 7,500 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $14,368 | 0.00% | 400 | Common | SOLE |
| 29286M105 | — | ENGENE HOLDINGS INC | $13,002 | 0.00% | 1,970 | Common | SOLE |
| 071705107 | BLCO | BAUSCH PLUS LOMB CORP | $11,574 | 0.00% | 600 | Common | SOLE |
| 37962G128 | — | GLOBAL STAR ACQUISITION INC | $11,513 | 0.00% | 88,560 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $10,611 | 0.00% | 50 | Common | SOLE |
| G89229135 | — | TMT ACQUISITION CORP | $10,128 | 0.00% | 37,100 | Common | SOLE |
| 00654J206 | ADXN | ADDEX THERAPEUTICS LTD | $9,770 | 0.00% | 1,000 | Common | SOLE |
| 36151G600 | GBS1EUR | INTELLIGENT BIO SOLUTIONS IN | $9,323 | 0.00% | 5,389 | Common | SOLE |
| G5212E113 | — | JVSPAC ACQUISITION CORP | $8,109 | 0.00% | 30,000 | Common | SOLE |
| 02156V109 | OKLO | OKLO INC | $8,090 | 0.00% | 1,000 | Common | SOLE |
| 38000Q102 | GLYCEUR | GLYCOMIMETICS INC | $7,723 | 0.00% | 45,700 | Common | SOLE |
| 57055L206 | MRKR | MARKER THERAPEUTICS INC | $6,858 | 0.00% | 2,432 | Common | SOLE |
| 29446K106 | EQ | EQUILLIUM INC | $6,089 | 0.00% | 7,318 | Common | SOLE |
| 56600D107 | MRVI | MARAVAI LIFESCIENCES HLDGS I | $5,817 | 0.00% | 700 | Common | SOLE |
| 462837121 | — | IRON HORSE ACQUISITIONS CORP | $4,250 | 0.00% | 25,000 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $3,616 | 0.00% | 200 | Common | SOLE |
| G1148A119 | BKHAR | BLACK HAWK ACQUISITION CORP | $3,480 | 0.00% | 3,000 | Common | SOLE |
| G4740B105 | ICHR | ICHOR HOLDINGS | $3,435 | 0.00% | 108 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $3,204 | 0.00% | 100 | Common | SOLE |
| 37962G110 | — | GLOBAL STAR ACQUISITION INC | $2,400 | 0.00% | 120,000 | Common | SOLE |
| 606710200 | MITK | MITEK SYS INC | $1,734 | 0.00% | 200 | Common | SOLE |
| G3034H141 | EMCRF | EMBRACE CHANGE ACQUISITN COR | $1,446 | 0.00% | 13,144 | Common | SOLE |
| G01490104 | — | AI TRANSN ACQUISITION CORP | $1,275 | 0.00% | 7,500 | Common | SOLE |
| 02157Q109 | ANRO | ALTO NEUROSCIENCE INC | $1,144 | 0.00% | 100 | PUT | SOLE |
| 462837113 | UCFIW | IRON HORSE ACQUISITIONS CORP | $768 | 0.00% | 25,000 | Common | SOLE |
| 36119D111 | FTIIW | FUTURETECH II ACQUISITION CO | $762 | 0.00% | 30,000 | Common | SOLE |
| 004468500 | ACHV | ACHIEVE LIFE SCIENCES INC | $431 | 0.00% | 91 | Common | SOLE |
| G0135E126 | AIMWF | AIMFINITY INVESTMENT CORP I | $362 | 0.00% | 18,000 | Common | SOLE |
| G3034H125 | EMCWF | EMBRACE CHANGE ACQUISITN COR | $265 | 0.00% | 18,000 | Common | SOLE |
| G6209W116 | MKDWW | MKDWELL TECH INC | $60 | 0.00% | 3,270 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.